Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease
SARS-CoV-2 vaccination provides lasting serologic response and protection against severe COVID-19 for most children with IBD, despite the use of lower vaccine doses in younger children and wide-ranging classes of immunosuppressive therapies.
Authors
- Michael D. Kappelman (ORCID: https://orcid.org/0000-0002-0469-6856)
- Ann M. Firestine (ORCID: https://orcid.org/0000-0001-9734-9687)
- Raymond K. Cross (ORCID: https://orcid.org/0000-0001-9766-5196)
- Jennifer Strople (ORCID: https://orcid.org/0000-0001-5357-9755)
- Kimberly N. Weaver (ORCID: https://orcid.org/0000-0002-7407-370X)
- Marla C. Dubinsky (ORCID: https://orcid.org/0000-0003-4968-5795)
- Runa Watkins (ORCID: https://orcid.org/0000-0003-3152-6446)
- Francis A. Farraye (ORCID: https://orcid.org/0000-0001-6371-2441)
- Peter D R Higgins
- Monique Bastidas (ORCID: https://orcid.org/0000-0003-1562-9576)
- Ryan C. Ungaro (ORCID: https://orcid.org/0000-0001-8687-3758)
- Athos Bousvaros
- Michael Zikry
- Erica J. Brenner (ORCID: https://orcid.org/0000-0003-0292-3637)
- Margie Boccieri (ORCID: https://orcid.org/0009-0007-1639-6192)
- Emanuelle Bellaguarda
- Arthur Kastl (ORCID: https://orcid.org/0000-0002-2625-9390)
- Meenakshi Bewtra (ORCID: https://orcid.org/0000-0002-6489-7043)
- Millie D. Long (ORCID: https://orcid.org/0000-0001-5983-2758)
- Riley Craig
- Xiangfeng Dai (ORCID: https://orcid.org/0000-0002-5985-1745)
- Kelly Chun (ORCID: https://orcid.org/0000-0001-5063-2805)
- Xian Zhang (ORCID: https://orcid.org/0000-0003-3572-6971)
- Wenli Chen (ORCID: https://orcid.org/0000-0002-6486-0582)
- Jeremy Adler (ORCID: https://orcid.org/0000-0002-4857-6098)
Institutions
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Maryland, Baltimore (US)
- Boston Children's Hospital (US)
- Lurie Children's Hospital (US)
- Allegheny Health Network (US)
- Children's Hospital of Philadelphia (US)
- Harvard University (US)
- University of Michigan (US)
- LabCorp (United States) (US)
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
- University of Pennsylvania (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1093/ibd/izae225
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Gilead Sciences
- Leona M. and Harry B. Helmsley Charitable Trust
- Kenneth Rainin Foundation
- Braintree Laboratories
- Crohn's and Colitis Foundation
- Celltrion
- National Institutes of Health
- Genentech
- Janssen Pharmaceuticals